Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that data from preclinical studies of the Company’s internally ...
Jose Castillo and Simone Jacot are undergraduate researchers who participated in the Microbiome Research summer program.
A hypoallergenic therapeutic vaccine candidate for peanut allergy was safe and tolerable, according to a poster presented at ...
Traws Pharma (TRAW) announced that data supporting the potential for tivoxavir marboxil as a bird flu treatment was presented yesterday in a ...
15h
News Medical on MSNELRIG announces Prof Rory Johnson and Dr Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025ELRIG meeting on Therapeutic Oligonucleotides brings together esteemed scientists from academia, industry, and other members ...
Preclinical and Phase 1 data suggest that ratutrelvir can be used without ritonavir and may reduce the likelihood of COVID rebound and the risk ...
6d
Apartment Therapy on MSNI Left My Marriage and Moved Out. Learning to "Be Alone" Changed My LifeGwyneth Paltrow spoke to Vanity Fair as part of a new cover story and pulled back the curtain a bit on her big return to ...
Poster underscores Tivoxavir Marboxil's potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, potent suppression of resistant viruses and Phase 1 dataFull da ...
2d
The Texas Tribune on MSNTexas’ DEI debate centers on a disagreement about whether programs perpetuate or prevent discriminationSupporters say diversity initiatives close educational and income gaps born from a history of prejudice. Republican officials ...
2d
Irish Examiner on MSNSouth Sudan: Cholera outbreak latest calamity to hit displaced peopleA cholera outbreak in Ireland in 1832-33 saw 76% death rates in some areas. Numbers in South Sudan are expected to spiral ...
Toshiba and the National Science Teaching Association (NSTA) announced today the regional winners of the 33rd annual ExploraVision program, the largest K-12 science competition designed to build ...
Neurocrine Biosciences, Inc. today presented new data from the long-term, open-label KINECT® 4 study demonstrating remission of tardive dyskinesia among the majority of patients treated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results